Funding: New Awards

Marc Ernstoff, MD
Professor of Medicine
Immunology and Cancer Immunotherapy

  • Eisai, Inc.
    An Open-Label, 2-Cohort, Multicenter, Phase 2 Study of E7080 in Previously Treated Subjects with Unresectable Stage III or Stage IV Melanoma

Camilo Fadul, MD
Professor of Medicine
Immunology and Cancer Immunotherapy

  • Dana Farber/Partners Cancer Care
    A Randomized Placebo-Controlled Trial of Armodafinil (Nuvigil) for Fatigue in Patients with Malignant Gliomas Undergoing Radiotherapy with or without Standard Chemotherapy Treatment

Elliott Fisher, MD, MPH
Professor of Medicine and Community and Family Medicine
Cancer Control

  • Robert Wood Johnson Foundation
    Strengthening the role of the Dartmouth Atlas of Health Care in improving health care under reform

Gary Schwartz, MD
Associate Professor of Medicine 
Molecular Therapeutics

    Randomized Phase III Trial of Paclitaxel Combined With Trastuzumab, Lapatinib, or Both as Neoadjuvant Treatment of Her2-Positive Primary Breast Cancer

Michael Sporn, MD
Professor of Pharmacology & Toxicology and of Medicine 
Molecular Therapeutics

  • Breast Cancer Research Foundation
    Chemoprevention of ER-negative breast cancer